Literature DB >> 26185383

Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.

Brice Andring1, Sanjeeva P Kalva1, Patrick Sutphin1, Rajiv Srinivasa1, Alvin Anene1, Marc Burrell1, Yin Xi1, Anil K Pillai1.   

Abstract

AIM: To assess the effect of technical parameters on outcomes of transjugular intrahepatic portosystemic shunt (TIPS) created using a stent graft.
METHODS: The medical records of 68 patients who underwent TIPS placement with a stent graft from 2008 to 2014 were reviewed by two radiologists blinded to the patient outcomes. Digital Subtraction Angiographic images with a measuring catheter in two orthogonal planes was used to determine the TIPS stent-to-inferior vena cava distance (SIVCD), hepatic vein to parenchymal tract angle (HVTA), portal vein to parenchymal tract angle (PVTA), and the accessed portal vein. The length and diameter of the TIPS stent and the use of concurrent variceal embolization were recorded by review of the patient's procedure note. Data on re-intervention within 30 d of TIPS placement, recurrence of symptoms, and survival were collected through the patient's chart. Cox proportional regression analysis was performed to assess the effect of these technical parameters on primary patency of TIPS, time to recurrence of symptoms, and all-cause mortality.
RESULTS: There was no significant association between the SIVCD and primary patency (P = 0.23), time to recurrence of symptoms (P = 0.83), or all-cause mortality (P = 0.18). The 3, 6, and 12-mo primary patency rates for a SIVCD ≥ 1.5 cm were 82.4%, 64.7%, and 50.3% compared to 89.3%, 83.8%, and 60.6% for a SIVCD of < 1.5 cm (P = 0.29). The median time to stenosis for a SIVCD of ≥ 1.5 cm was 19.1 mo vs 15.1 mo for a SIVCD of < 1.5 cm (P = 0.48). There was no significant association between the following factors and primary patency: HVTA (P = 0.99), PVTA (P = 0.65), accessed portal vein (P = 0.35), TIPS stent diameter (P = 0.93), TIPS stent length (P = 0.48), concurrent variceal embolization (P = 0.13) and reinterventions within 30 d (P = 0.24). Furthermore, there was no correlation between these technical parameters and time to recurrence of symptoms or all-cause mortality. Recurrence of symptoms was associated with stent graft stenosis (P = 0.03).
CONCLUSION: TIPS stent-to-caval distance and other parameters have no significant effect on primary patency, time to recurrence of symptoms, or all-cause mortality following TIPS with a stent-graft.

Entities:  

Keywords:  Mortality; Outcomes; Portal Hypertension; Stents; Technique; Transjugular intrahepatic portosystemic shunt

Mesh:

Year:  2015        PMID: 26185383      PMCID: PMC4499354          DOI: 10.3748/wjg.v21.i26.8110

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients.

Authors:  J M LaBerge; K A Somberg; J R Lake; R L Gordon; R K Kerlan; N L Ascher; J P Roberts; M M Simor; C A Doherty; J Hahn
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

2.  Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction.

Authors:  R Y Kanterman; M D Darcy; W D Middleton; K M Sterling; S A Teefey; T K Pilgram
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

3.  Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.

Authors:  M Rössle; P Deibert; K Haag; A Ochs; M Olschewski; V Siegerstetter; K H Hauenstein; R Geiger; C Stiepak; W Keller; H E Blum
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

4.  Effect of polytetrafluoroethylene covering of Palmaz stents on the development of intimal hyperplasia in human iliac arteries.

Authors:  M L Marin; F J Veith; J Cynamon; R E Parsons; R T Lyon; W D Suggs; C W Bakal; S Waahl; L A Sanchez; J G Yuan; T Ohki
Journal:  J Vasc Interv Radiol       Date:  1996 Sep-Oct       Impact factor: 3.464

5.  The role of duplex and colour Doppler ultrasound in the follow-up evaluation of transjugular intrahepatic portosystemic stent shunt (TIPSS).

Authors:  J M Ferguson; R Jalan; D N Redhead; P C Hayes; P L Allan
Journal:  Br J Radiol       Date:  1995-06       Impact factor: 3.039

6.  Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement.

Authors:  Z J Haskal; J Zuckerman
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

7.  Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine.

Authors:  R R Saxon; J Mendel-Hartvig; C L Corless; J Rabkin; B T Uchida; K Nishimine; F S Keller
Journal:  J Vasc Interv Radiol       Date:  1996 Jul-Aug       Impact factor: 3.464

8.  Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation.

Authors:  F Menegaux; E B Keeffe; E Baker; H Egawa; W Concepcion; T R Russell; C O Esquivel
Journal:  Arch Surg       Date:  1994-10

9.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.

Authors:  J Cabrera; M Maynar; R Granados; E Gorriz; R Reyes; J M Pulido-Duque; J L Rodriguez SanRoman; C Guerra; D Kravetz
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

10.  Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.

Authors:  R M Strauss; L G Martin; S L Kaufman; T D Boyer
Journal:  Am J Gastroenterol       Date:  1994-09       Impact factor: 10.864

View more
  5 in total

1.  Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.

Authors:  Shawn H Sun; Thomas Eche; Chloé Dorczynski; Philippe Otal; Paul Revel-Mouroz; Charline Zadro; Ephraim Partouche; Nadim Fares; Charlotte Maulat; Christophe Bureau; Lawrence H Schwartz; Hervé Rousseau; Laurent Dercle; Fatima-Zohra Mokrane
Journal:  Eur Radiol       Date:  2022-01-11       Impact factor: 5.315

2.  Impact of PTFE-covered stent position and extension on TIPS patency.

Authors:  Joshua K Cho; Juan Serna; Timothy W I Clark; Mandeep Dagli; Jeffrey I Mondschein; Richard D Shlansky-Goldberg; Scott O Trerotola; Michael C Soulen; S William Stavropoulos; Gregory J Nadolski
Journal:  Abdom Radiol (NY)       Date:  2020-11

3.  Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation.

Authors:  Benjamin Moulin; Olivier Chevallier; Gilles Abdulmalak; Maxime Luu; Marianne Latournerie; Anne Minello; Sophie Gehin; Jean-Pierre Cercueil; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2018-03

4.  Cranial stent position is independently associated with the development of TIPS dysfunction.

Authors:  Carsten Meyer; Alba Maria Paar Pérez; Johannes Chang; Alois Martin Sprinkart; Nina Böhling; Andreas Minh Luu; Daniel Kütting; Christian Jansen; Julian Luetkens; Leon Marcel Bischoff; Ulrike Attenberger; Christian P Strassburg; Jonel Trebicka; Karsten Wolter; Michael Praktiknjo
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

5.  Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt.

Authors:  Shi-Hua Luo; Jian-Guo Chu; He Huang; Ke-Chun Yao
Journal:  World J Gastroenterol       Date:  2017-07-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.